Skip to main content
Publications
Rebordosa C , Farkas DK, Montonen J, Laugesen K, Voss F, Aguado J , Bothner U, Rothman KJ , Zint K, Mines DI , Ehrenstein V. Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists . Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):827-39. doi: 10.1002/pds.5432
Rebordosa C , Houben E, Laugesen K, Asmar J, Montonen JT, Aguado J , Overbeek J, Ehrenstein V, Wallace L, Gilsenan A . Utilization of olodaterol and indacaterol in Europe . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):1128. doi: 10.1002/pds.4864
Plana E , Rivero-Ferrer E , Aguado J , Saigi-Morgui N , Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S , Rebordosa C . Hospitalization for heart failure among patients using aclidinium bromide and other COPD medications: a post-authorisation safety study in the CPRD . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):1153. doi: 10.1002/pds.4864
Saigi N , Rebordosa C , Bui C , Aguado J , Plana E , Nuevo J, Daoud SZ, Lei A, Perez-Gutthann S , Rivero-Ferrer E . A validation exercise: identifying hospitalizations for heart failure among patients with COPD in the CPRD . Poster presented at the 35th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2019. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2019 Aug 20; 28(S2):334. doi: 10.1002/pds.4864
Rebordosa C , Castellsague J, Kristiansen N, Pottegard A, Plana E , Aguado J , Garcia-Gil E, Hallas J, Perez-Gutthann S . Severity of COPD in new users of aclidinium bromide and other COPD medications: a population-based study in the United Kingdom and Denmark . Presented at the 33rd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 28, 2017. Montreal, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2017 Aug; 26(Suppl 2):45-6. doi: 10.1002/pds
Johannes CB , McQuay LJ, Midkiff KD , Calingaert B , Andrews EB, Tennis P, Brown JS, Camargo, Jr CA, DiSantostefano R, Rothman KJ , Sturmer T, Lanes S, Davis KJ. The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality . Pharmacoepidemiol Drug Saf. 2017 Apr;26(4):446-58. doi: 10.1002/pds.4151